1 recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
Follow BCD-248 + daratumumab: new trials by email Literature Review of BCD-248 + daratumumab trials Research Report on BCD-248 + daratumumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of the Efficacy and Safety of BCD-248 in Combination With Daratumumab in Patients With Relapsed or Refractory Multiple Myeloma (AMMADINA) BCD-248 + daratumumab, Daratumumab + pomalidomide + dexamethasone - Myeloma Multiple | Phase 3 | Recruiting | Biocad | 390 | 2026-06-15 | 2026-08-03 |
Multiple Myeloma (1)
Biocad (1)
Belarus (1) · Russia (1)
Arina Zinkina (1)